- Home
- RRX vs CAI Comparison
RRX vs CAI Comparison
Compare RRX & CAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RRX
- CAI
- Stock Information
- Founded
- RRX 1955
- CAI 2008
- Country
- RRX United States
- CAI United States
- Employees
- RRX N/A
- CAI N/A
- Industry
- RRX
- CAI Medical Specialities
- Sector
- RRX
- CAI Health Care
- Exchange
- RRX Nasdaq
- CAI Nasdaq
- Market Cap
- RRX 10.4B
- CAI 9.4B
- IPO Year
- RRX 1987
- CAI 2025
- Fundamental
- Price
- RRX $138.76
- CAI $34.06
- Analyst Decision
- RRX Strong Buy
- CAI Strong Buy
- Analyst Count
- RRX 9
- CAI 6
- Target Price
- RRX $178.56
- CAI $35.50
- AVG Volume (30 Days)
- RRX 682.8K
- CAI 564.6K
- Earning Date
- RRX 11-03-2025
- CAI 11-12-2025
- Dividend Yield
- RRX 1.01%
- CAI N/A
- EPS Growth
- RRX N/A
- CAI N/A
- EPS
- RRX 3.76
- CAI N/A
- Revenue
- RRX $5,852,700,000.00
- CAI $533,847,000.00
- Revenue This Year
- RRX N/A
- CAI $59.70
- Revenue Next Year
- RRX $3.96
- CAI $50.34
- P/E Ratio
- RRX $36.90
- CAI N/A
- Revenue Growth
- RRX N/A
- CAI 106.53
- 52 Week Low
- RRX $90.56
- CAI $25.40
- 52 Week High
- RRX $185.28
- CAI $42.50
- Technical
- Relative Strength Index (RSI)
- RRX 40.62
- CAI N/A
- Support Level
- RRX $140.15
- CAI N/A
- Resistance Level
- RRX $146.02
- CAI N/A
- Average True Range (ATR)
- RRX 4.26
- CAI 0.00
- MACD
- RRX -0.88
- CAI 0.00
- Stochastic Oscillator
- RRX 2.42
- CAI 0.00
About RRX Regal Rexnord Corporation
Regal Rexnord Corp is in the engineering and manufacturing of industrial powertrain solutions, power transmission components, electric motors, electronic controls, air-moving products, and specialty electrical components and systems, serving customers around the world. The four operating segments include Commercial Systems, Industrial Systems, Climate Solutions, and Motion Control Solutions.
About CAI Caris Life Sciences Inc. Common Stock
Caris Life Sciences Inc is a patient-centric, next-generation AI TechBio company. It develop and commercialize solutions to transform healthcare through the use of comprehensive molecular information and artificial intelligence/machine learning algorithms at scale.